RSS-Feed abonnieren

DOI: 10.1055/s-0045-1802578
Mucormycosis and Hearing: A Hospital-Based Study
Funding The authors declare that they did not receive funding from agencies in the public, private or non-profit sectors to conduct the present study.

Abstract
Introduction Mucormycosis, a fungal infection with severe consequences, gained prominence during the coronavirus disease 2019 (COVID-19) pandemic. While significant efforts were made to understand the systemic implications of mucormycosis, its effect on the auditory system remains unexplored.
Objective This study aimed to investigate the auditory implications of mucormycosis through a comprehensive case-control study focusing on hearing loss and middle ear dysfunction.
Methods A total of 30 mucormycosis patients without prior auditory issues, and 30 age and gender-matched controls, underwent comprehensive hearing assessment, including pure-tone and immittance audiometry. Statistical analyses, including descriptive statistics, Mann-Whitney U test, Pearson chi-square test, and multiple logistic regression were performed to analyze the data.
Result Mucormycosis patients exhibited significantly higher auditory thresholds across all frequencies compared to controls (p < 0.05). Approximately half of these patients experienced some degree of hearing loss, predominantly mild. Immittance measurement showed a higher prevalence of abnormal tympanograms in mucormycosis patients, indicating middle ear dysfunction. Acoustic reflex was absent in half of the mucormycosis patients suggesting impaired auditory function.
Conclusion The present study revealed significant auditory health impacts of mucormycosis, finding a notable prevalence of hearing loss and middle ear dysfunction, which emphasizes the need for routine audiological evaluations and increased awareness of mucormycosis-related auditory issues. Despite the study's limitations, we identified potential risk factors for hearing impairment, suggesting a need for further large-scale studies to confirm these findings and understand the mechanisms. These insights aim to improve diagnosis, treatment, and prevention strategies for better clinical outcomes.
Keywords
mucormycosis - hearing loss - auditory system - middle ear dysfunction - pure-tone audiometry - acoustic immittancePublikationsverlauf
Eingereicht: 19. Oktober 2023
Angenommen: 17. November 2024
Artikel online veröffentlicht:
07. August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Monalisa Jati, Ripu Daman Arora, Ruuzeno Koutsu, Nitin M. Nagarkar, Roshan Marandi, Kartik Agrawal. Mucormycosis and Hearing: A Hospital-Based Study. Int Arch Otorhinolaryngol 2025; 29: s00451802578.
DOI: 10.1055/s-0045-1802578
-
References
- 1 Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a Viral Land: A Tale of Two Pathogens. Indian J Ophthalmol 2021; 69 (02) 244-252
- 2 Petrikkos G, Tsioutis C. Recent Advances in the Pathogenesis of Mucormycoses. Clin Ther 2018; 40 (06) 894-902
- 3 Ibrahim AS, Kontoyiannis DP. Update on mucormycosis pathogenesis. Curr Opin Infect Dis 2013; 26 (06) 508-515
- 4 Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Rhinol Otol 2021; 135 (05) 442-447
- 5 Mahalaxmi I, Jayaramayya K, Venkatesan D. et al. Mucormycosis: An opportunistic pathogen during COVID-19. Environ Res 2021; 201: 111643
- 6 Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15 (04) 102146
- 7 Jeong W, Keighley C, Wolfe R. et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect 2019; 25 (01) 26-34
- 8 Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med 2021; 42: 264.e5-264.e8
- 9 Chander J, Kaur M, Singla N. et al. Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India. J Fungi (Basel) 2018; 4 (02) 46
- 10 Kumar M, Sarma DK, Shubham S. et al. Mucormycosis in COVID-19 pandemic: Risk factors and linkages. Curr Res Microb Sci 2021; 2: 100057
- 11 Hoenigl M, Seidel D, Carvalho A. et al; ECMM and ISHAM collaborators. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe 2022; 3 (07) e543-e552
- 12 Nordvik Ø, Laugen Heggdal PO, Brännström J, Vassbotn F, Aarstad AK, Aarstad HJ. Generic quality of life in persons with hearing loss: a systematic literature review. BMC Ear Nose Throat Disord 2018; 18: 1
- 13 Tuzcu A, Bahceci M, Celen MK, Kilinc N, Ozmen S. Necrotizing (malignant) otitis externa: an unusual localization of mucormycosis. Indian J Med Microbiol 2006; 24 (04) 289-291
- 14 Biniyam K, Bhat V, Bhandary SK, Aroor R. Asymptomatic mucormycosis of middle ear: An incidental finding during tympanoplasty. Indian J Otol 2014; 20 (02) 83
- 15 Bellazreg F, Hattab Z, Meksi S. et al. Outcome of mucormycosis after treatment: report of five cases. New Microbes New Infect 2014; 6: 49-52
- 16 Kermani W, Bouttay R, Belcadhi M, Zaghouani H, Ben Ali M, Abdelkéfi M. ENT mucormycosis. Report of 4 cases. Eur Ann Otorhinolaryngol Head Neck Dis 2016; 133 (02) 83-86
- 17 Hazarika P, Zachariah J, Victor J, John M, Devi C, Abraham P. Mucormycosis of the middle ear: a case report with review of literature. Indian J Otolaryngol Head Neck Surg 2012; 64 (01) 90-94
- 18 Kumar P, Goyal S, Prabhu P. Blackfungus due to covid-19: Audiological Assessment of middle ear functioning. Aud Vestib Res. 2021; 30 (04) 300-305
- 19 Jati M, Koutsu R, Nagarkar NM. Rhino-Cerebral Mucormycosis with Otologic Involvement. Indian J Otolaryngol Head Neck Surg 2022; 74 (Suppl. 02) 3517-3520
- 20 Carl AC, Hohman MH, Cornejo J. Audiology Pure Tone Evaluation. [Updated 2023 Mar 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK580531/
- 21 Carhart R, Jerger J. Preferred methods for clinical determination of pure-tone thresholds. J Speech Hear Res 1959; 24: 330-345
- 22 Katz J, Marshall C, English K, Hood L, Tillery K. Handbook of Clinical Audiology. Philadelphia: Lippincott Williams & Wilkins; 2015
- 23 Prakash H, Ghosh AK, Rudramurthy SM. et al. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med Mycol 2019; 57 (04) 395-402
- 24 Shah V, Ganapathy H, Gopalakrishnan R, Geetha N. A Rare Case of Facial Palsy Due to Mucormycosis. International Journal of Otolaryngology and Head & Neck Surgery. 2015; 04 (03) 224
- 25 Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18 (03) 556-569
- 26 Ben-Ami R, Luna M, Lewis RE, Walsh TJ, Kontoyiannis DP. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J Infect 2009; 59 (02) 134-138
- 27 Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012; 54 (Suppl 1, Suppl 1) S16-S22